Presentations and articles on rheumatology
From background info and laboratory expertise up to patient stories – we share our knowledge with you!
Another piece of the puzzle in rheumatological diagnostics
Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. They are diagnosed on the clinical history, imaging techniques, and serological tests. Antibody detection is a useful diagnostic tool and can provide essential information for differential diagnostics. However, it is not always possible to detect autoantibodies, as not all target antigens have been discovered yet and detection systems are not yet available for every autoantibody.
Read more
No one-size-fits-all – antibody detection in rheumatology
Autoantibody testing is becoming increasingly important in rheumatological diagnostics. It delivers crucial information for differential diagnostics and sometimes even allows prediction of the disease progression or helps in the choice of therapy. Before diagnostic use, all serological tests undergo thorough investigation. They are only approved when they meet the respective criteria. However, a result obtained from these serological tests should never be the sole basis of a diagnosis as discrepancies may occur due to the very nature of autoimmunity.
Read more
Reliable, fast and easy – IFA diagnostics in rheumatology
Indirect immunofluorescence assays (IFAs) such as for anti-nuclear antibody (ANA) testing are an important diagnostic tool in rheumatology. However, manual processing and evaluation of IFAs requires trained professionals and a lot of time. With innovative solutions and modern technologies, EUROIMMUN makes an important contribution to continuous development in immunofluorescence diagnostics and thus increases reliability, efficiency and standardisation.
Read more
Covering all bases – our portfolio for rheumatology
Diagnostics of the different autoimmune-related rheumatic diseases pose a particular challenge to rheumatologists: They are confronted with at least 400 inflammatory joint, connective tissue or vascular diseases, which include subgroups sometimes requiring different treatments, and cause a great variety of symptoms. In addition to symptoms, specific antibodies are characterising features. But while there is great number of different antibodies, the prevalence is very low for some of them, making detection very challenging. However, for differential diagnostics in particular, autoantibody detection can give crucial hints and thus enable a fast therapy start for patients.
Read more
A life-saving diagnosis thanks to comprehensive antibody testing – a motivating success story
In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease that mainly affects the connective tissue and muscles. Today he is treated with immunosuppressants and is doing well, but receiving this diagnosis and successful therapy did not come easy.
Read more
The perfect match for routine laboratories of all sizes
EUROIMMUN has been building expertise in immunofluorescence diagnostics since the 1980s. The indirect immunofluorescence assay (IFA) serves as an essential screening method for detecting many types of autoantibodies. It offers a broad antigen spectrum due to the use of cells and tissues as antigenic substrates. Thanks to our in-house research and development as well as own production facilities, we are able to design optimal solutions to meet our customers’ needs.
Card title
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.
